Publication: Characterization of COPD Admissions During the First COVID-19 Outbreak.
dc.contributor.author | Cosio, Borja G | |
dc.contributor.author | Shafiek, Hanaa | |
dc.contributor.author | Toledo-Pons, Nuria | |
dc.contributor.author | Iglesias, Amanda | |
dc.contributor.author | Barcelo, Margalida | |
dc.contributor.author | Represas-Represas, Cristina | |
dc.contributor.author | Comeche, Lorena | |
dc.contributor.author | Catalan, Pablo | |
dc.contributor.author | Fernandez-Villar, Alberto | |
dc.contributor.author | Lopez-Campos, Jose Luis | |
dc.contributor.author | Echave-Sustaeta, Jose | |
dc.contributor.author | Soler-Cataluna, Juan Jose | |
dc.date.accessioned | 2023-02-09T11:40:22Z | |
dc.date.available | 2023-02-09T11:40:22Z | |
dc.date.issued | 2021-06-03 | |
dc.description.abstract | Exacerbations of COPD (ECOPD) are a frequent cause of hospitalization that seemed to ameliorate during the COVID outbreak. We aimed to evaluate the clinical characteristics of COPD-related hospital admissions and mortality in relation to the presence of COVID-19. We conducted a case-control study of patients admitted in four teaching hospitals throughout Spain between March 15 and April 30, 2020. Hospital admissions of respiratory cause with and without PCR-proven SARS-CoV-2 infection in patients with COPD were evaluated. Baseline and episode-related clinical characteristics were analyzed. Logistic regression analysis was performed to evaluate the risk for mortality. During the study period, 2101 patients were admitted for respiratory worsening, 1200 (57.1%) with COVID-19. A total of 228 (10.8%) were admitted due to COPD worsening, of whom 52 (22.8%) tested positive for COVID-19. COPD patients with COVID-19, when compared to those without COVID-19, were more frequently males with better lung function (FEV1 postbronchodilator 71% vs 46% respectively, p Hospitalizations for ECOPD without COVID-19 were more frequent than COPD with COVID-19 during the first outbreak, but the latter were associated with higher mortality and low eosinophil counts that warrant further analysis. | |
dc.identifier.doi | 10.2147/COPD.S312493 | |
dc.identifier.essn | 1178-2005 | |
dc.identifier.pmc | PMC8184145 | |
dc.identifier.pmid | 34113088 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184145/pdf | |
dc.identifier.unpaywallURL | https://www.dovepress.com/getfile.php?fileID=70196 | |
dc.identifier.uri | http://hdl.handle.net/10668/17987 | |
dc.journal.title | International journal of chronic obstructive pulmonary disease | |
dc.journal.titleabbreviation | Int J Chron Obstruct Pulmon Dis | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | 1549-1554 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.rights | Attribution-NonCommercial 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject | COPD exacerbation | |
dc.subject | hospitalization | |
dc.subject | inhaled corticosteroids | |
dc.subject | mortality | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Case-Control Studies | |
dc.subject.mesh | Disease Outbreaks | |
dc.subject.mesh | Hospitalization | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Pulmonary Disease, Chronic Obstructive | |
dc.subject.mesh | SARS-CoV-2 | |
dc.subject.mesh | Spain | |
dc.title | Characterization of COPD Admissions During the First COVID-19 Outbreak. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 16 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1